MethanexLogo.jpg
Methanex Renews and Adds New Tranche to Revolving Credit Facility
April 24, 2024 17:00 ET | Methanex Corporation
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (NASDAQ:MEOH) announced today that it has renewed its US$300 million revolving credit facility, which...
CHAMPION.jpg
ChampionX Reports First Quarter 2024 Results
April 24, 2024 17:00 ET | ChampionX Corporation
Revenue of $922.1 million, decreased 3% year-over-yearNet income attributable to ChampionX of $112.9 million, increased 78% year-over-yearAdjusted net income of $96.4 million, increased 17%...
Logo.png
Marathon Digital Holdings Schedules Conference Call for First Quarter 2024 Financial Results
April 24, 2024 16:54 ET | Marathon Digital Holdings Inc.
Earnings Webcast and Conference Call Set for Thursday, May 9, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, April 24, 2024 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon"...
Logo.png
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
April 24, 2024 16:51 ET | Ocean Biomedical, Inc.
PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market...
Amedisys Logo.jpg
Amedisys Reports First Quarter 2024 Financial Results
April 24, 2024 16:45 ET | Amedisys, Inc.
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended...
1947989_CVB-Grey Logo 12-14-2020.jpg
CVB Financial Corp. Reports Earnings for the First Quarter 2024
April 24, 2024 16:45 ET | CVB Financial Corp
First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21%Return on Average Tangible Common Equity of 15.13% Net Interest Margin of 3.10% ...
NKGen Biotech RGB.jpg
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 16:45 ET | NKGen Biotech, Inc.
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and...
Riot Announces First
Riot Announces First Quarter 2024 Earnings Conference Call
April 24, 2024 16:45 ET | Riot Platforms, Inc
Castle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry leader in vertically integrated Bitcoin (“BTC”) mining, announced today...
Nanobiotix logo.jpg
NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR L’ANNÉE 2023
April 24, 2024 16:40 ET | Nanobiotix S.A.
L’accord de licence globale de co-développement et de commercialisation avec Janssen Pharmaceutica NV (« Janssen ») étend le potentiel du radioenhancer NBTXR3 à l’échelle internationale.La survie...
Nanobiotix logo.jpg
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
April 24, 2024 16:40 ET | Nanobiotix S.A.
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102...